POTASSIUM PHOSPHATE
Kidney Calculi
National Center for Research Resources (NCRR)mixturePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Kidney Calculi cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
POTASSIUM CITRATE National Center for Research Resources (NCRR) | Phase 3 | BB |
LIDOCAINE Hans Bahlmann | Phase 3 | B |
NEPENTHE Hans Bahlmann | Phase 3 | B |
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE Hans Bahlmann | Phase 3 | B |
Bmn 255 BioMarin Pharmaceutical | Phase 1 | CC |
Ketorolac Tromethamine Hamilton Health Sciences Corporation | Phase 3 | NR |
Same molecule, other indications
POTASSIUM PHOSPHATE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →